Send Message
Wuhan Desheng Biochemical Technology Co., Ltd
Wuhan Desheng Biochemical Technology Co., Ltd
news
Home / news /

Company News About Hubei Xindesheng Material Technology Co., Ltd. shines at the 2025 CMEF exhibition

Hubei Xindesheng Material Technology Co., Ltd. shines at the 2025 CMEF exhibition

2025-04-02
Hubei Xindesheng Material Technology Co., Ltd. shines at the 2025 CMEF exhibition

In today's rapidly advancing medical technology, every technological leap is a significant improvement in ensuring human health. In the season of spring in 2025, the global medical industry's attention will be focused on Shanghai, and the 91st China International Medical Equipment Fair Spring Exhibition (CMEF) is about to grandly open. At this grand event that gathers the world's top medical technology and innovative achievements, Hubei Xindesheng Material Technology Co., Ltd. (hereinafter referred to as "Xindesheng") will showcase the latest achievements in China's in vitro diagnostic reagent field to the world with its star products, outstanding research and development capabilities, and forward-looking technological vision.


Focusing on in vitro diagnostics, deeply cultivating the field of blood vessel additives for blood collection


As a leader in the in vitro diagnostic reagent industry, Xindesheng has always been committed to the research and production of key products such as blood collection tube additives, chromogenic substrates, chemiluminescence reagents, and biological buffering agents. For this exhibition, Xindesheng carefully selected some highlight products, aiming to bring more efficient and safer diagnostic solutions to global medical customers.


Serum separation gel: displays four different colors of serum separation gel, which not only meets the visual differentiation needs of different laboratories, but also ensures the purity and stability of samples with its excellent separation performance, providing a solid foundation for subsequent testing.


Efficient coagulants and anticoagulants: New Desheng provides two types of coagulants suspension and high-efficiency coagulants powder for different detection needs, as well as reagents for different anticoagulant systems such as EDTA dipotassium, tripotassium, heparin sodium, heparin lithium, sodium citrate, potassium oxalate, etc. Whether it is rapid coagulation analysis or the need to maintain liquid samples for a long time, the best match can be found here to ensure the accuracy of test results.


High performance silicification agent: Through unique silicification treatment technology, it effectively reduces the interaction between the inner wall of the blood collection tube and the sample, improves the efficiency of sample collection, and ensures the integrity of the sample, creating favorable conditions for high-precision detection.


Biological buffer: a solid support for scientific research and clinical practice


The selection of buffering agents is crucial in biological research. The series of biological buffering agents brought by Xindesheng, including tris, mops, hepes, caps, ADA, tes, etc., have become the first choice for many scientific research institutions and clinical laboratories due to their excellent pH stability, low toxicity, and wide application compatibility. These buffering agents not only support experimental needs in various research fields from molecular biology to cell culture, but also greatly promote innovation and development of in vitro diagnostic technology.


Innovation driven, working together to create the future


Xindesheng is well aware that innovation is the core driving force behind the advancement of medical technology. Therefore, the company continues to increase its R&D investment, introduce international advanced equipment and technology, and build a R&D team composed of professional researchers, committed to developing more high-quality products that meet international standards. Through continuous technological innovation and optimization, Xindesheng is gradually building a global sales and service network, providing more convenient and efficient solutions for global customers.


CMEF stage, jointly painting a new chapter in healthcare


The CMEF Spring Exhibition in 2025 is not only a stage for Xindesheng to showcase its latest technological achievements, but also a valuable opportunity for communication, mutual learning, and common development with industry colleagues. New Desheng looks forward to collaborating with partners, experts, scholars, and representatives of medical institutions from around the world to explore the future trends in the field of in vitro diagnostics, work together to promote the development of global healthcare, and jointly draw a beautiful blueprint for human health.


At the upcoming CMEF event, Hubei Xindesheng Material Technology Co., Ltd. cordially invites you to visit our booth and witness the infinite possibilities of medical technology together, creating a brilliant future for a healthy world!